Schedule 13E-3

Schedule 13E-3

A form that a company must file with the SEC during a management buyout. That is, the schedule 13E-3 is filed when the senior management of a publicly-traded company buys all of the company's shares outstanding. A schedule 13E-3 is necessary because it stops trade on the company's stock and allows the company to operate without recourse to shareholders.

Schedule 13E-3

An SEC form that must be filed when a company is taken private. See also going private.
Mentioned in ?
References in periodicals archive ?
In connection with the proposed merger, the company has filed a transaction statement on Schedule 13E-3, a preliminary proxy statement and related materials with the Securities and Exchange Commission, and expects to file an amendment to the Schedule 13E-3 and updated proxy materials with the SEC in a timely manner.
The plan has been approved by the Cimetrix board of directors and is fully disclosed in the SEC Schedule 13E-3 filing, which is available at www.
This information amends the previously filed Schedule 13E-3 Transaction Statement by the group taking the company private through a short form merger.
Shenzhen-based pharmaceutical company Tongjitang Chinese Medicines Company (NYSE:TCM) revealed on Monday that it has filed a going-private transaction statement on Schedule 13E-3 with the US Securities and Exchange Commission (SEC) on the basis of the proposed merger agreement between the company and Fosun Industrial Co Ltd, Hanmax Investment Ltd and Tonsun International Company Ltd.
The company has filed with the US Securities and Exchange Commission (SEC) a Schedule 13E-3 transaction statement and a related preliminary redemption notice/transaction statement.
Making this announcement on Wednesday, the company said that it intends to file a Schedule 13E-3 with respect to the proposed offer with the US Securities and Exchange Commission and submit the necessary court filings to the Courts of the British Virgin Islands with respect to the proposed offer as soon as possible.
1% of Digital Lightwave's outstanding shares filed a Schedule 13E-3, concerning the merger, with the US Securities and Exchange Commission on Wednesday.
A preliminary proxy statement and Schedule 13E-3 will soon be filed with the US Securities and Exchange Commission (SEC) to initiate the reverse/forward stock split.